Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
First-time investors can benefit greatly from expert advice. Learn key strategies to navigate the investment landscape effectively.
28,248 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
A newCapital Economics note warns that the current rotation in U.S. equities could be a forerunner to a broader corre...
Rigetti Computing stock rocketing headlines a broader burst of investor interest in quantum tech. Here’s what’s drivi...
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
A regional bank melt-up: this market moment could offer outsized gains, but it comes with sharp risks. Learn how to e...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
This article breaks down pattern group (ptrn) 2025 earnings with a clear view of what to watch in the quarterly trans...
SoFi posted stronger Q1 2026 results, but the stock remains depressed as investors weigh the path to sustained profit...
A closer look at dividend aristocrats with multi-decade payout streaks and what their steady income track means for i...
ZoomInfo's go-to-market approach is evolving as 2026 unfolds. This analysis breaks down the GTM moves behind the earn...
PBDC, a focused BDC ETF, slashed its April 2026 payout by about 14% to $0.71273 per share. With shares near $27 and a...